Concepedia
Statistics
Publications
4
Citations
278
H-Index
Active since
1995
Affiliations
GlaxoSmithKline (United States)(Current)
Research Triangle Park Foundation
Burroughs Wellcome Fund
Alex J. Daniels is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicine, and physiology.
Top concepts
MedicinePharmacologyPhysiologyEndocrinologyPharmacotherapyNeuropharmacologyObesityNeuroscienceAnesthesiologyDrug Discovery
Publications per year
1995–2006
High-affinity neuropeptide Y receptor antagonists.
Alex J. Daniels, Jessica Matthews, Ruta Slepetis et al. · Proceedings of the National Academy of Sciences · 1995 · 139 citations · Full text
Neuropeptides, Sympathetic Nerve Terminals, Pharmacotherapy +18
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats
Mikhail Kalinichev, Claire Rourke, Alex J. Daniels et al. · Psychopharmacology · 2005 · 71 citations
Obesity, Medicine, Physiology +8
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
Donald L. Hertzog, Kamal Albarazanji, Eric C. Bigham et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text
Medicine, Rational Drug Design, Mechanism Of Action +3
Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.
Alex J. Daniels, Jessica Matthews, O. Humberto Viveros et al. · Molecular Pharmacology · 1995 · 21 citations
1–4 of 4